HARMONIC PHARMA

Company profile

HARMONIC PHARMA company profile

HARMONIC PHARMA’s core innovation is theirunique know-how based on the polypharmacology paradigm to characterize new uses, molecular substitution and safety profile of small molecules from diverse sources. They identify an extensive set of biological targets of therapeutic compoundsThey’re not restricted to new molecules either. Their approach has already been successfully tested using known molecules for which They found new applications. Their work on small molecules has carried out in the pharmaceutical, cosmetics, neutraceutical, chemistry and industrial areas. The 4th of December 2017, Novacap (currently Seqens group) announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau,..... For more information, log in to dureach.com to view the full company profile.